Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study

Παρόμοια τεκμήρια

• Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
  ανά: Li, Xin, κ.ά.
  Έκδοση: (2018)
• Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
  ανά: Wei, Zhigang, κ.ά.
  Έκδοση: (2017)
• Mechanisms of resistance to EGFR tyrosine kinase inhibitors
  ανά: Huang, Lihua, κ.ά.
  Έκδοση: (2015)
• Skin problems and EGFR-tyrosine kinase inhibitor
  ανά: Kozuki, Toshiyuki
  Έκδοση: (2016)
• Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions
  ανά: Yang Li, κ.ά.
  Έκδοση: (2025-04-01)